Advertisement

Topics

SYGNIS AG - Successful acquisition of Innova Biosciences

10:04 EDT 5 Jul 2017 | Bionity

SYGNIS AG announced that the Company has successfully completed its acquisition of Innova Biosciences Ltd. SYGNIS AG paid EUR 10.8 million, consisting of EUR 8 million in cash and 2 million shares of SYGNIS AG as a contribution in kind. Depending on agreed performance indicators, the purchase price ...

Original Article: SYGNIS AG - Successful acquisition of Innova Biosciences

NEXT ARTICLE

More From BioPortfolio on "SYGNIS AG - Successful acquisition of Innova Biosciences"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...